Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of ITeos Therapeutics Inc (NASDAQ: ITOS) closed at $7.19 in the last session, down -4.39% from day before closing price of $7.52. In other words, the price has decreased by -$4.39 from its previous closing price. On the day, 0.51 million shares were traded. ITOS stock price reached its highest trading level at $7.65 during the session, while it also had its lowest trading level at $7.14.
Ratios:
We take a closer look at ITOS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.62 and its Current Ratio is at 12.62. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 13, 2024, initiated with a Overweight rating and assigned the stock a target price of $31.
On May 05, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $37.
On October 08, 2020, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $45.Robert W. Baird initiated its Outperform rating on October 08, 2020, with a $45 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Gall Matthew bought 5,000 shares for $7.73 per share. The transaction valued at 38,635 led to the insider holds 65,429 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ITOS now has a Market Capitalization of 274617024 and an Enterprise Value of -214934688. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.85 while its Price-to-Book (P/B) ratio in mrq is 0.45. Its current Enterprise Value per Revenue stands at -6.141 whereas that against EBITDA is 1.382.
Stock Price History:
The Beta on a monthly basis for ITOS is 1.31, which has changed by -0.3348751 over the last 52 weeks, in comparison to a change of 0.07903516 over the same period for the S&P500. Over the past 52 weeks, ITOS has reached a high of $18.75, while it has fallen to a 52-week low of $6.67. The 50-Day Moving Average of the stock is -3.89%, while the 200-Day Moving Average is calculated to be -36.72%.
Shares Statistics:
According to the various share statistics, ITOS traded on average about 363.47K shares per day over the past 3-months and 463280 shares per day over the past 10 days. A total of 36.57M shares are outstanding, with a floating share count of 33.15M. Insiders hold about 13.20% of the company’s shares, while institutions hold 78.28% stake in the company. Shares short for ITOS as of 1740700800 were 1280718 with a Short Ratio of 3.52, compared to 1738281600 on 1405639. Therefore, it implies a Short% of Shares Outstanding of 1280718 and a Short% of Float of 6.0500003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
